Every year on Human Rights Day, we reflect on the principles enshrined in the Universal Declaration of Human Rights (UDHR): dignity, equality, and protection for all.
These values are not only foundational to society but also central to the way we conduct clinical research, here at MAC and across the clinical trials industry. At the heart of every trial is a commitment to respect and safeguard the rights of participants, ensuring that science advances without compromising human ethics.
What are Clinical Trials?
Clinical trials are integral to the advancement of healthcare and typically involve participants testing potential new treatments, medications, or devices.
Did you know, between 2024 and 2025, over one million people took part in clinical research across England according to an NIHR report1.
By recognising the potential vulnerabilities of participants in clinical trials, the Human Rights Act serves as a powerful tool to safeguard their rights and well-being.
GCP and the UDHR: A Shared Commitment
Good Clinical Practice (GCP) is the ethical and scientific quality standard for designing, conducting, and reporting clinical trials. Its principles align closely with the UDHR, reinforcing that research must prioritise human dignity, equality, and protection.
Dignity: GCP ensures that participants are treated as autonomous individuals, capable of making informed decisions about their involvement or their right to withdraw from a clinical trial at any point. Informed consent is not just a formality, it is a process that empowers participants with clear, honest information about risks, benefits, and alternatives. This respect for autonomy reflects Article 1 of the UDHR: “All human beings are born free and equal in dignity and rights”2.
Equality: Clinical trials must be inclusive and non-discriminatory. Recruitment strategies should ensure fair access, regardless of gender, ethnicity, or socioeconomic status. This commitment echoes Article 2 of the UDHR, which prohibits discrimination and guarantees equal rights for all2.
Protection: GCP requires robust safeguards for participant safety and privacy. Independent ethics committees review protocols to minimise risk and uphold welfare. Data confidentiality is strictly maintained, ensuring that personal information remains secure. These protections mirror the UDHR’s emphasis on security of person and privacy2.
Ethics at the Core of Research
Ethical oversight is integral to clinical research. Every trial undergoes rigorous ethical review to confirm that any potential risks are justified by potential benefits and that vulnerable populations receive special consideration. Researchers are accountable for maintaining transparency, integrity, and respect throughout the study lifecycle.
Participating in a Clinical Trial
As we celebrate Human Rights Day, it’s crucial to acknowledge the integral role of the Human Rights Act in upholding the dignity and well-being of those who choose to participate in clinical research. Through this intersection of human rights and clinical trials, we can strive for advancements in healthcare that are not only scientifically groundbreaking but also equitable, ethically sound and socially just.
Here at MAC Clinical Research, our friendly, welcoming team is committed to fostering an environment for patients to feel comfortable and safe when taking part in a clinical trial at our clinics.
When you take part in a clinical trial with MAC, not only will you receive the utmost care from our specialist teams, but you’ll also receive a full comprehensive health check-up, which may include an ECG, blood pressure, and blood tests.
If you are interested in taking part in a clinical trial at MAC, find out if there’s one suitable via our current trials webpage.
Depending on the trial, you may receive financial reimbursement for taking part. Reasonable travel expenses or transportation for clinic visits will be provided.
1 NIHR – RDN Portfolio Data
2 United Nations – Universal Declaration of Human Rights
